Subjects

On this page readers can obtain a listing of documents under the subject headings. Click on the name of a subject heading to display the sub-headings, or to return to the main subjects. Click on the icon of a sub-heading to obtain the concerned documents. Publications are available in HTML, PDF , DOC or XLS format. Click on the corresponding icon to open the publication. The PDF icon located on the cover page of a publication represents that the publication is available only in PDF format. If the PDF icon is located near the title of the publication it means the document is available in both HTML and PDF formats.
Expand the sub-collections menu.
305 documents on 1 page
 
 
 
 
Open this document and view its content

Adverse Event Reporting on Antiretroviral Medicines in KwaZulu-Natal for April 2007 to March 2012

Year:

2014;

Pages:

50;


Related documents:

 
Open this document and view its content

Antiretroviral Cohort Adverse Event Monitoring In Kwazulu-Natal, April 2014

Year:

2014;

Pages:

110;


 
Open this document and view its content

Assessment of the Regulatory Systems and Capacity of the Directorate General for Drug Administration in Bangladesh

Year:

2012;

Pages:

73;


 
Open this document and view its content

Clinical Trials Have Gone Global: Is This a Good Thing?

Year:

2012;

Pages:

5;

Related documents:

Regions:

 
Open this document and view its content

Comprehensive Assessment of Pharmacovigilance Systems and their Performance in Sub-Saharan Africa

Year:

2012;

Pages:

1;


 
Open this document and view its content

Designing a National Combined Reporting Form for Adverse Drug Reactions and Medication Errors - Malta

Year:

2015;

Pages:

10;

Countries:

 
Open this document and view its content

Development of a Risk-Based Approach and Tools for Improving Safe and Rational Use of Tuberculosis Medicines

Year:

2013;

Pages:

40;


Regions:

 
Open this document and view its content

Emergency Use Assessment and Listing Procedure (EUAL) for Candidate in Vitro Diagnostics (IVDs) for Use in the Context of a Public Health Emergency

Year:

2015;

Pages:

11;


Regions:

 
Open this document and view its content

Emergency Use Assessment and Listing Procedure (EUAL) for Candidate Medicines for Use in the Context of a Public Health Emergency

Year:

2015;

Pages:

9;


Regions:

 
Open this document and view its content

Emergency Use Assessment and Listing Procedure (EUAL) for Candidate Vaccines for Use in the Context of a Public Health Emergency

Year:

2015;

Pages:

10;


Regions:

 
Open this document and view its content

Farmacovigilancia, hacia una mayor seguridad en el uso de medicamentos - 2012

Year:

2012;

Pages:

329;


 
 
Open this document and view its content

Governance and Pharmacovigilance in Brazil: A Scoping Review

Year:

2016;

Pages:

15;

Countries:

 
Open this document and view its content

Guideline for Good Clinical Practice. ICH Harmonised Tripartite Guideline. E6(R1). Current Step 4 version, dated 10 June 1996. (including the Post Step 4 corrections). The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

Year:

1996;

Pages:

59;


 
Open this document and view its content

Guidelines for evaluation of drugs for use in man : report of a WHO scientific group - WHO Technical Report Series, No. 563 (Russian version) [English] [French] [Spanish]

Year:

1975;

Pages:

72;


Regions:

 
Open this document and view its content

Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis

Year:

2016;

Pages:

15;

Related documents:

Countries:

 
Open this document and view its content

Implementing Active Pharmacovigilance and Cohort Event Monitoring for Multidrug-Resistant Tuberculosis Regimens in the Philippines, April 2015

Year:

2015;

Pages:

67;


Related documents:

 
Open this document and view its content

Meeting of the NEPAD Regional Centers of Regulatory Excellence (RCORES) in Pharmacovigilance. May 14–15, 2015, Accra, Ghana. Report of Proceedings

Year:

2015;

Pages:

30;


 
Open this document and view its content

Pharmacovigilance Monitoring System - PViMS

Year:

2015;

Pages:

2;


Related documents:

Regions:

 
Open this document and view its content

Post-marketing Withdrawal of 462 Medicinal Products Because of Adverse Drug Reactions: A Systematic Review of the World Literature

Year:

2016;

Pages:

11;

Related documents:

Regions:

 
Open this document and view its content

Quality of Medicines Multi-Stakeholder Forum. Kampala, May 2015 - Uganda Medicines Transparency Alliance (MeTA)

Year:

2015;

Pages:

19;


Countries:

 
Open this document and view its content

Rapid Evaluation of Medicine Use and Pharmacovigilance in Angola: July to August 2011

Year:

2011;

Pages:

69;


Countries:

 
Open this document and view its content

Registration and Quality Assurance of ARVs & Other Essential Medicines in Namibia. October 2014 - September 2015

Year:

2015;

Pages:

21;


Related documents:

Countries:

 
Open this document and view its content

Report on Post-Market Surveillance of First Line Anti-Tuberculosis Medicines in Kenya

Year:

2012;

Pages:

78;


Countries:

 
Open this document and view its content

Report on Technical Assistance for Drug Information and Pharmacovigilance Activities of the DI & ADR Centre in Vietnam

Year:

2010;

Pages:

108;


Related documents:

Countries:

 
Open this document and view its content

Safety of Medicinal Products in the Philippines: Assessment of the Pharmacovigilance System and its Performance. January 2013

Year:

2013;

Pages:

68;


Related documents:

 
Open this document and view its content

Screening Drug Quality Project. Report, March 2014 - Uganda Medicines Transparency Alliance (MeTA)

Year:

2014;

Pages:

27;


Countries:

 
Open this document and view its content

Screening Drug Quality Project. Report, November 2015 - Uganda Medicines Transparency Alliance (MeTA)

Year:

2015;

Pages:

35;


Countries:

 
Open this document and view its content

Sentinel Site–Based Pilot Active Surveillance Pharmacovigilance in the Vietnam ART Program

Year:

2010;

Pages:

39;


Countries:

 
Open this document and view its content

SIAPS Annual Report: Program Year 1, October 2011–September 2012. Systems for Improved Access to Pharmaceuticals and Services Program

Year:

2012;

Pages:

40;


Regions:

 
Open this document and view its content

SIAPS Annual Report: Program Year 2, October 2012–September 2013. Systems for Improved Access to Pharmaceuticals and Services Program

Year:

2013;

Pages:

63;


Regions:

 
Open this document and view its content

SIAPS Annual Report: Program Year 3, October 2013–September 2014. Systems for Improved Access to Pharmaceuticals and Services Program

Year:

2014;

Pages:

174;


Regions:

 
Open this document and view its content

SIAPS Annual Report: Program Year 4, October 2014–September 2015. Systems for Improved Access to Pharmaceuticals and Services Program

Year:

2015;

Pages:

268;


Regions:

 
Open this document and view its content

Standard Operating Procedures. Active Pharmacovigilance Surveillance: Drug Safety Monitoring for New Medicines and Novel Regimens of the National TB Program in the Philippines

Year:

2015;

Pages:

21;


 
Open this document and view its content

Strengthening Research Capacity on Safety, Efficacy and Quality of Care of Traditional Medicine. Report of a Regional Expert Group Meeting, New Delhi, 11–13 December 2013

Year:

2014;

Pages:

50;


 
Open this document and view its content

Strengthening the Nevirapine Safety Signal by Using the Electronic Dispensing Tool in Namibia

Year:

2013;

Pages:

28;


Countries:

 
Open this document and view its content

Technical Assistance for the Development of Pre-service and In-service Pharmacovigilance Curriculum at the Hanoi University of Pharmacy in Vietnam

Year:

2011;

Pages:

41;


Countries:

 
Open this document and view its content

WHA 16.36 - Клиническая и фармакологическая оценка фармацевтических препаратов. Всемирная ассамблея здравоохранения, 16 сессия, 1963 / WHA16.36 - Clinical and Pharmacological Evaluation of Drugs. WHA resolution; The Sixteenth World Health Assembly, 1963 [English] [French] [Spanish]

Year:

1963;

Pages:

3;


Regions:

 
Open this document and view its content

WHA17.39 - Клиническая и фармакологическая оценка лекарственных препаратов. Всемирная ассамблея здравоохранения, 17 сессия / (WHA17.39 - Clinical and Pharmacological Evaluation of Drugs. WHA resolution; The Seventeenth World Health Assembly, 1964) [English] [French] [Spanish]

Year:

1964;

Pages:

2;


Regions:

 
Open this document and view its content

WHA18.42 - Система контроля за вредными воздействиями лекарственных препаратов. Всемирная ассамблея здравоохранения, 18 сессия, 1965 / WHA18.42 - Adverse Drug Reaction Monitoring System. WHA resolution; The Eighteenth World Health Assembly, 1965 [English] [French] [Spanish]

Year:

1965;

Pages:

2;


Regions:

 
Open this document and view its content

WHA24.56 - Качество, безопасность и эффективность лекарственных препаратов. Всемирная ассамблея здравоохранения, 24 сессия / WHA24.56 - Quality, safety and efficacy of drugs. WHA resolution; The Twenty-fourth World Health Assembly, 1971 [English] [French] [Spanish]

Year:

1971;

Pages:

2;


Regions:

 
Open this document and view its content

The WHO Collaborating Centre for International Drug Monitoring. (WHO Drug Information Vol. 30, No. 1, 2016)

Year:

2016;

Pages:

5;


Regions:

 
Open this document and view its content

WHO Pharmacovigilance Indicators: a Practical Manual for the Assessment of Pharmacovigilance Systems

Year:

2015;

Pages:

84;


Related documents:

Regions:

 
Open this document and view its content

The World Medicines Situation 2011 (Chapters Currently Available)

Year:

2011;

Pages:

360;


Regions: